vs

Side-by-side financial comparison of AGCO CORP (AGCO) and CME Group (CME). Click either name above to swap in a different company.

AGCO CORP is the larger business by last-quarter revenue ($2.9B vs $1.9B, roughly 1.6× CME Group). AGCO CORP runs the higher net margin — 3.3% vs 0.1%, a 3.2% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 1.1%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -0.1%).

AGCO Corporation is an American agricultural machinery manufacturer headquartered in Duluth, Georgia, United States. It was founded in 1990. AGCO designs, produces and sells tractors, combines, foragers, hay tools, self-propelled sprayers, smart farming technologies, seeding equipment, and tillage equipment.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

AGCO vs CME — Head-to-Head

Bigger by revenue
AGCO
AGCO
1.6× larger
AGCO
$2.9B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+13.3% gap
CME
14.5%
1.1%
AGCO
Higher net margin
AGCO
AGCO
3.2% more per $
AGCO
3.3%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-0.1%
AGCO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AGCO
AGCO
CME
CME
Revenue
$2.9B
$1.9B
Net Profit
$95.5M
$1.2M
Gross Margin
25.4%
Operating Margin
7.9%
0.1%
Net Margin
3.3%
0.1%
Revenue YoY
1.1%
14.5%
Net Profit YoY
137.3%
20.7%
EPS (diluted)
$1.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGCO
AGCO
CME
CME
Q1 26
$1.9B
Q4 25
$2.9B
$1.6B
Q3 25
$2.5B
$1.5B
Q2 25
$2.6B
$1.7B
Q1 25
$2.1B
$1.6B
Q4 24
$2.9B
$1.5B
Q3 24
$2.6B
$1.6B
Q2 24
$3.2B
$1.5B
Net Profit
AGCO
AGCO
CME
CME
Q1 26
$1.2M
Q4 25
$95.5M
$1.2B
Q3 25
$305.7M
$908.0M
Q2 25
$314.8M
$1.0B
Q1 25
$10.5M
$956.2M
Q4 24
$-255.7M
$874.6M
Q3 24
$30.0M
$912.8M
Q2 24
$-367.1M
$883.2M
Gross Margin
AGCO
AGCO
CME
CME
Q1 26
Q4 25
25.4%
Q3 25
26.1%
Q2 25
25.0%
Q1 25
25.4%
Q4 24
23.9%
Q3 24
23.2%
Q2 24
25.8%
Operating Margin
AGCO
AGCO
CME
CME
Q1 26
0.1%
Q4 25
7.9%
61.8%
Q3 25
6.1%
63.3%
Q2 25
6.2%
66.7%
Q1 25
2.4%
67.5%
Q4 24
-9.3%
62.1%
Q3 24
4.4%
64.6%
Q2 24
-7.4%
65.3%
Net Margin
AGCO
AGCO
CME
CME
Q1 26
0.1%
Q4 25
3.3%
71.7%
Q3 25
12.3%
59.1%
Q2 25
11.9%
60.6%
Q1 25
0.5%
58.2%
Q4 24
-8.9%
57.3%
Q3 24
1.2%
57.6%
Q2 24
-11.3%
57.6%
EPS (diluted)
AGCO
AGCO
CME
CME
Q1 26
Q4 25
$1.30
$3.24
Q3 25
$4.09
$2.49
Q2 25
$4.22
$2.81
Q1 25
$0.14
$2.62
Q4 24
$-3.42
$2.40
Q3 24
$0.40
$2.50
Q2 24
$-4.92
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGCO
AGCO
CME
CME
Cash + ST InvestmentsLiquidity on hand
$861.8M
$2.4B
Total DebtLower is stronger
$2.4B
$3.4B
Stockholders' EquityBook value
$4.3B
Total Assets
$11.9B
$202.0B
Debt / EquityLower = less leverage
0.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGCO
AGCO
CME
CME
Q1 26
$2.4B
Q4 25
$861.8M
$4.5B
Q3 25
$884.1M
$2.6B
Q2 25
$783.9M
$2.1B
Q1 25
$562.6M
$1.5B
Q4 24
$612.7M
$3.0B
Q3 24
$622.6M
$2.4B
Q2 24
$657.3M
$1.9B
Total Debt
AGCO
AGCO
CME
CME
Q1 26
$3.4B
Q4 25
$2.4B
Q3 25
$2.7B
Q2 25
$2.8B
Q1 25
$2.8B
Q4 24
$2.6B
Q3 24
$4.0B
Q2 24
$3.9B
Stockholders' Equity
AGCO
AGCO
CME
CME
Q1 26
Q4 25
$4.3B
$28.7B
Q3 25
$4.5B
$28.2B
Q2 25
$4.2B
$27.7B
Q1 25
$3.8B
$27.0B
Q4 24
$3.7B
$26.5B
Q3 24
$4.1B
$28.2B
Q2 24
$4.1B
$27.6B
Total Assets
AGCO
AGCO
CME
CME
Q1 26
$202.0B
Q4 25
$11.9B
$198.4B
Q3 25
$12.5B
$187.1B
Q2 25
$12.3B
$179.9B
Q1 25
$11.5B
$157.8B
Q4 24
$11.2B
$137.4B
Q3 24
$13.5B
$137.8B
Q2 24
$13.6B
$123.4B
Debt / Equity
AGCO
AGCO
CME
CME
Q1 26
Q4 25
0.56×
Q3 25
0.61×
Q2 25
0.68×
Q1 25
0.74×
Q4 24
0.68×
Q3 24
0.95×
Q2 24
0.95×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGCO
AGCO
CME
CME
Operating Cash FlowLast quarter
$763.6M
Free Cash FlowOCF − Capex
$675.0M
FCF MarginFCF / Revenue
23.1%
Capex IntensityCapex / Revenue
3.0%
Cash ConversionOCF / Net Profit
8.00×
TTM Free Cash FlowTrailing 4 quarters
$740.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGCO
AGCO
CME
CME
Q1 26
Q4 25
$763.6M
$1.1B
Q3 25
$71.0M
$968.1M
Q2 25
$365.7M
$1.1B
Q1 25
$-212.2M
$1.1B
Q4 24
$797.9M
$1.0B
Q3 24
$26.5M
$1.0B
Q2 24
$235.5M
$776.9M
Free Cash Flow
AGCO
AGCO
CME
CME
Q1 26
Q4 25
$675.0M
$1.1B
Q3 25
$2.1M
$949.7M
Q2 25
$323.5M
$1.0B
Q1 25
$-260.4M
$1.1B
Q4 24
$683.9M
$991.7M
Q3 24
$-59.8M
$973.2M
Q2 24
$137.5M
$758.7M
FCF Margin
AGCO
AGCO
CME
CME
Q1 26
Q4 25
23.1%
66.8%
Q3 25
0.1%
61.8%
Q2 25
12.3%
61.5%
Q1 25
-12.7%
67.1%
Q4 24
23.7%
65.0%
Q3 24
-2.3%
61.4%
Q2 24
4.2%
49.5%
Capex Intensity
AGCO
AGCO
CME
CME
Q1 26
Q4 25
3.0%
2.0%
Q3 25
2.8%
1.2%
Q2 25
1.6%
1.1%
Q1 25
2.4%
0.9%
Q4 24
3.9%
1.7%
Q3 24
3.3%
1.9%
Q2 24
3.0%
1.2%
Cash Conversion
AGCO
AGCO
CME
CME
Q1 26
Q4 25
8.00×
0.96×
Q3 25
0.23×
1.07×
Q2 25
1.16×
1.03×
Q1 25
-20.21×
1.17×
Q4 24
1.16×
Q3 24
0.88×
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons